Logotype for Dimed S.A. Distribuidora de Medicamentos

Dimed (PNVL3) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Dimed S.A. Distribuidora de Medicamentos

Q4 2025 earnings summary

30 Aug, 2026

Executive summary

  • Retail gross revenue grew 17.0% year-over-year to R$5.91 billion in 2025, with 18.2% growth in 4Q25 and strong same-store sales (+14.7%) and mature store sales (+11.6%) in the quarter.

  • Digital sales surged 46.8% to R$1.5 billion, reaching 28.6% penetration in 4Q25, with app sales up 56.9% and strong loyalty initiatives.

  • Adjusted EBITDA rose 21.4% to R$319.4 million (5.4% margin), and adjusted net income increased 15.3% to R$135.3 million (2.3% margin); 4Q25 adjusted net income up 35.0%.

  • Market share in the Southern Region reached a record 13.9%, marking the 23rd consecutive quarter of regional share gains.

  • Ended the year with 659 stores, completing the exit from wholesale and focusing fully on retail.

Financial highlights

  • Retail gross revenue: R$5,912 million in 2025 (+17.0% YoY); 4Q25: R$1,678 million (+18.2% YoY).

  • Adjusted EBITDA: R$319.4 million (+21.4% YoY), margin 5.4%; 4Q25: R$104.8 million (+27.9% YoY), margin 6.2%.

  • Adjusted net income: R$135.3 million (+15.3% YoY), margin 2.3%; 4Q25: R$45.2 million (+35.0% YoY), margin 2.7%.

  • Free cash flow was R$106.3 million in 2025, with positive cash generation every quarter and net debt/EBITDA reduced to 0.9x.

  • Retail gross margin stable at 29.8% in 2025; ROIC for mature stores reached 25.2% in 2024.

Outlook and guidance

  • 2030 guidance: gross revenue R$11.5–12.0 billion, adjusted EBITDA margin 6.7–7.0%, and 950–1,000 stores.

  • Growth drivers include higher average sales per store, regional expansion, digitalization, generics, private label, and AI-driven pricing.

  • Expense growth expected to remain below revenue growth, supported by productivity and automation.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more